VIVEVE MED INC
VIVE
VIVE was delisted on the 18th of January, 2023.
50 hedge funds and large institutions have $76.9M invested in VIVEVE MED INC in 2018 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 5 reducing their positions, and 4 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 5
175% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 4
25% more capital invested
Capital invested by funds: $61.4M → $76.9M (+$15.5M)
14% more funds holding
Funds holding: 44 → 50 (+6)
3.68% more ownership
Funds ownership: 63.56% → 67.24% (+3.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less call options, than puts
Call options by funds: $1.1M | Put options by funds: $1.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$12.4M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$3.93M |
| 3 |
RI
RTW Investments
New York
|
+$3.85M |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
+$3.48M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
+$2.17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFS
Amtrust Financial Services
New York
|
-$117K |
| 2 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$79K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$56.5K |
| 4 |
MA
MYDA Advisors
Woodmere,
New York
|
-$47.8K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$26.1K |
VIVE Hedge Fund Activity: Q1 2018 in Review
50 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q1 2018, worth a combined $76.9M — up 25% from $61.4M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new VIVE positions and 4 closed out — a net gain of 7 holders — while 25 added to existing stakes and 5 trimmed.
The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $12.4M. The largest seller was Amtrust Financial Services, cutting an estimated $117K.
- 50 institutional investors held VIVEVE MED INC (VIVE) as of Q1 2018, up from 44 in Q4 2017.
- Funds reported $76.9M of VIVEVE MED INC stock for Q1 2018, up 25% quarter-over-quarter.
- 11 funds opened new VIVEVE MED INC positions in Q1 2018 and 4 closed out, a net change of +7 holders.
- The largest VIVEVE MED INC buyer in Q1 2018 was Nantahala Capital Management, an estimated $12.4M added.
- The largest VIVEVE MED INC seller in Q1 2018 was Amtrust Financial Services, an estimated $117K sold.
Based on aggregated 13F filings for Q1 2018.